
Nilendra Singh
Business Lead – Global Pharma and pharmaceutical research scientist
Network
6.1K connectionsSummary
Work
Education
Projects
Writing
LL-00066471, a novel positive allosteric modulator of b17 nicotinic acetylcholine receptor ameliorates cognitive and sensorimotor gating deficits in animal models: Discovery and preclinical characterization
January 1, 2021A preclinical pharmacology study describing LL-00066471, an b17 nAChR positive allosteric modulator, with in vitro and in vivo characterization showing cognitive and sensorimotor benefits in animal models; Nilendra Singh is listed as a co-author affiliated with Lupin Research Park.
Intracerebral hemorrhage outcomes following selective blockade or stimulation of the PGE2 EP1 receptor
January 1, 2015Study on the role of the PGE2 EP1 receptor in intracerebral hemorrhage models; Nilendra Singh is a listed co-author with University of Florida affiliation on this BMC Neuroscience paper.
Similar profiles
Kartheek A
22K connections
SMShouvik Mondal
Assistant Professor at Netaji Subhas University
16.5K connections
MSMohammed Salman
Application Specialist at Sedeer Medical
13.8K connections
RCrashmi chaturvedi
Chief Strategy Officer at ProVanta Life Tech
5.4K connections
PKPradip Kokane
Manager at Medreich Limited
7.7K connections
SKSmita Karpate
Founder and CEO at NXT Health
10K connections